Merck and Pfizer Pull PR Coup With Corning Glass Partnership
This time, when Donald Trump hosted an event with two Big Pharma CEOs, the topic wasn’t drug pricing: it was jobs in American manufacturing, tied to a new, stronger glass vial. But it also looks like an early case study in effective engagement with an unpredictable White House.
You may also be interested in...
The US president made what seemed to be a retaliatory statement about high drug prices after Merck CEO Ken Frazier resigned from his jobs council.
Before taking over the US health department, Alex Azar helped bring landmark litigation challenging the scope of FDA’s regulatory authority under the First Amendment. Now his tenure is ending with a First Amendment defense of the agency.
In sign of how much has changed in four years, industry might be better off if Biden takes CAP’s advice and launches ‘march-in’ actions to address pricing of COVID products.